ACVR1, a therapeutic target of fibrodysplasia ossificans progressiva, is negatively regulated by miR-148a.
about
A Survey of Strategies to Modulate the Bone Morphogenetic Protein Signaling Pathway: Current and Future PerspectivesRegulation of ACVR1 and ID2 by cell-secreted exosomes during follicle maturation in the mare.Molecular, phenotypic aspects and therapeutic horizons of rare genetic bone disorders.MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis.The microRNA-148/152 family: multi-faceted playersInduced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation.miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer.Effects of miR-146a on the osteogenesis of adipose-derived mesenchymal stem cells and bone regeneration.A genetic variant of miR-148a binding site in the SCRN1 3'-UTR is associated with susceptibility and prognosis of gastric cancerRole of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease.The microRNA regulatory network: a far-reaching approach to the regulate the Wnt signaling pathway in number of diseases.MicroRNAs Provide Feedback Regulation of Epithelial-Mesenchymal Transition Induced by Growth Factors.TGF-β Signaling from Receptors to Smads.The Horizon of a Therapy for Rare Genetic Diseases: A "Druggable" Future for Fibrodysplasia Ossificans Progressiva.Copy number variation as a genetic basis for heterotaxy and heterotaxy-spectrum congenital heart defects.miR-208a-3p Suppresses Osteoblast Differentiation and Inhibits Bone Formation by Targeting ACVR1.The Diverse Mechanisms of miRNAs and lncRNAs in the Maintenance of Liver Cancer Stem Cells.
P2860
Q26739015-A887A9A9-2DD3-40C5-B206-1BF87C9F06B3Q33712244-B780B4BA-2EF6-4777-AEF3-BC01F4B9B353Q34502398-BC6EB553-9ECA-43E4-8D7A-4A126C448F96Q35051475-6652CB51-DBB6-4A73-A7B9-24DFF1707B79Q36898251-9571AE8D-38A8-4168-8137-5BEFA8FD63E0Q37479896-4CFEC11C-527E-4536-9E66-7454BFE24782Q37603500-503D02D3-8DE1-4E42-A353-3CDBC0FBBDDAQ37644217-30E11F86-1424-41BC-A820-CD64C48060A3Q37739534-E2A1863A-86A2-4ED1-BC6A-F4DC4B777504Q38083596-E74F2F84-B37C-4B08-8A58-70104DF9394FQ38622178-8C119250-687B-4F16-B36B-9419BF30FFADQ38868815-A4F5A830-1172-4AC7-8F7D-0E820BC37FEBQ38906099-FED0530D-69CF-40BA-A85B-02F021934518Q52340220-0606361C-5A6C-4596-BF31-202FB7E2A2E9Q54163960-401D44FC-3DAB-44CF-87FC-4FB6F4E0B057Q55022278-13E8CC12-9F89-4AFC-82EF-2AB121581BB6Q55423816-D8F78FD1-42EE-456D-BC71-19E27635F681
P2860
ACVR1, a therapeutic target of fibrodysplasia ossificans progressiva, is negatively regulated by miR-148a.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
ACVR1, a therapeutic target of ...... atively regulated by miR-148a.
@ast
ACVR1, a therapeutic target of ...... atively regulated by miR-148a.
@en
type
label
ACVR1, a therapeutic target of ...... atively regulated by miR-148a.
@ast
ACVR1, a therapeutic target of ...... atively regulated by miR-148a.
@en
prefLabel
ACVR1, a therapeutic target of ...... atively regulated by miR-148a.
@ast
ACVR1, a therapeutic target of ...... atively regulated by miR-148a.
@en
P2093
P2860
P356
P1476
ACVR1, a therapeutic target of ...... atively regulated by miR-148a.
@en
P2093
P2860
P304
P356
10.3390/IJMS13022063
P407
P50
P577
2012-02-15T00:00:00Z